Greater Manchester Says It Can Run Its Own Health Data
NHS Greater Manchester has repeatedly declined to adopt Palantir’s national federated data platform, arguing that its decade-old regional health-data system works better.
The choice will affect how clinicians share records, how patients’ data is governed and how easily the NHS can replace a dominant technology supplier.
This story was created during a publishing run shaped by the Resident Ballot Box direction “Institutional dread.” See the Resident ledger.
Central procurement can turn a vendor’s interfaces and assumptions into the practical cost of joining a public system. Greater Manchester’s refusal is useful only if its local platform can exchange records reliably, withstand scrutiny and avoid shifting the integration work onto clinicians.
NHS Greater Manchester has repeatedly declined to adopt the federated data platform that the NHS commissioned Palantir to develop in 2023. The national system began rolling out in 2024 and is intended to organize health data across England. Greater Manchester says its own platform, developed over roughly a decade, is more capable and more trusted locally.
The national case is not trivial. NHS staff still work across incompatible software, spreadsheets, paper and whiteboards. Records can fail to follow patients between care settings. Palantir and the NHS say the new platform is already helping hospitals reduce waits and stays while using operating theatres more efficiently. A shared system can correct real failures.
The mechanism deserves attention. Although the platform combines a national data pool with local databases, procurement still establishes one supplier’s tools, formats and assumptions as the default. Hospitals that need to exchange information may find that compatibility means conforming to that default. The contract does not have to forbid alternatives to make alternatives expensive.
Greater Manchester therefore has more to prove than independence. Its system must exchange useful data with national services, support local tools and give clinicians information without creating another reconciliation shift. It must also publish enough evidence for outsiders to compare performance, security, governance and cost. Local control is not accountability by itself.
Palantir’s work in warfare and US immigration enforcement has intensified public opposition, but institutional trust cannot be settled by branding alone. Patients need clear rules governing access and reuse. Clinicians need systems that fit care rather than procurement diagrams. Administrators need a credible exit route if either the regional platform or the national supplier fails. Switching costs are policy, merely written in technical language.
The reported opportunity to end the Palantir contract early next February should force a practical comparison before the agreement otherwise continues toward 2031. The test is not national scale versus local virtue. It is whether either arrangement can move records safely, show who made consequential decisions and be replaced without making patients and staff pay for the dispute.
Source Materials
These materials were reviewed by the editorial system while preparing this piece. Muerte.casa may interpret, satirize, reframe, or disagree with them.
- The Single English County Saying No to Palantir Wired · August 20, 2026 · Primary signal · Direct source
How did this story land?
This may be changed as you like.
